Table 4 |
|||||||||
|
Correlation matrix |
|||||||||
|
PCNA |
P53 |
EGFR extent score |
EGFR Intensity score |
VEGF |
D2-40 positive tumor cells |
Intratumoral LVD |
Peritumoral LVD |
Total LVD |
|
|
|
|||||||||
|
P53 |
0.34(*) |
||||||||
|
|
|||||||||
|
EGFR extent score |
-0.19 |
0.16 |
|||||||
|
|
|||||||||
|
EGFR Intensity score |
0.03 |
0.01 |
0.25 |
||||||
|
|
|||||||||
|
VEGF |
0.07 |
0.11 |
0.18 |
0.25 |
|||||
|
|
|||||||||
|
D2-40 positive tumor cells |
-0.01 |
0.28 |
0.1 |
0.07 |
-0.09 |
||||
|
|
|||||||||
|
Intratumoral LVD |
0.07 |
0.26 |
0.35(*) |
0.33(*) |
0.08 |
0.39(*) |
|||
|
|
|||||||||
|
Peritumoral LVD |
0.01 |
-0.01 |
0.02 |
0.36(*) |
0.2 |
0.22 |
0.62(*) |
||
|
|
|||||||||
|
Total LVD |
0.07 |
0.11 |
0.18 |
0.36(*) |
0.15 |
0.32(*) |
0.85(*) |
0.92(*) |
|
|
|
|||||||||
|
Tumor staging |
-0.06 |
0.13 |
-0.09 |
0.09 |
-0.05 |
-0.26 |
-0.09 |
0.04 |
-0.04 |
|
|
|||||||||
|
Tumor grading |
-0.08 |
0.03 |
-0.01 |
0.05 |
0.09 |
0.15 |
0.2 |
0.43(*) |
0.32(*) |
|
|
|||||||||
|
Tumor size |
-0.06 |
0.01 |
-0.18 |
-0.13 |
-0.03 |
-0.32(*) |
-0.05 |
0.1 |
0.04 |
|
|
|||||||||
|
Lymph node staging |
-0.02 |
0.22 |
0.05 |
0.25 |
0.03 |
-0.08 |
-0.01 |
0.12 |
0.06 |
|
|
|||||||||
|
Age |
0.31 |
0.31 |
0.07 |
0.03 |
-0.2 |
0.08 |
-0.04 |
-0.28 |
-0.15 |
|
|
|||||||||
|
Sarkis et al. Head & Neck Oncology 2010 2:13 doi:10.1186/1758-3284-2-13 |
|||||||||
